News from novo nordisk A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 28, 2014, 08:30 ET

New US study shows some minority groups with diabetes experience positive psychological outcomes but report high levels of diabetes distress

 Results from an analysis of US respondents from Novo Nordisk's Diabetes Attitudes, Wishes and Needs 2 (DAWN2™) study were published...

Aug 25, 2014, 09:00 ET

Novo Nordisk Kicks Off HeroPath™ Life Coach Program for Teens and Young Adults With Hemophilia

 Novo Nordisk announced the launch of the HeroPath™ Life Coach Program, an empowering, yearlong program that connects teens and young...

Jul 07, 2014, 13:32 ET

FDA Approves NovoSeven® RT for the Treatment of Glanzmann's Thrombasthenia (GT) With Refractoriness

 Novo Nordisk today announced the US Food and Drug Administration (FDA) has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant])...

Jun 25, 2014, 08:00 ET
Dominique Wilkins' Diabetes Dream Team (PRNewsFoto/Novo Nordisk)

Novo Nordisk and NBA Legend Dominique Wilkins Spotlight Full-Court Approach to Type 2 Diabetes Management

Novo Nordisk is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to...

Jun 21, 2014, 14:00 ET

Phase 3a Liraglutide 3 mg Trial Demonstrated Significant Weight Loss and Improved Cardiovascular Risk Factors in Adults With Obesity and Type 2 Diabetes Compared With Placebo

Today, new data from the phase 3a SCALE™ Diabetes trial were presented at the International Congress of Endocrinology (ICE) and the...

Jun 21, 2014, 14:00 ET

New Phase 3a Liraglutide 3 mg Data Showed Positive Impact on Cardiovascular Risk Markers and Fewer People Progressing to Pre-Diabetes Compared With Placebo in Adults With Obesity

Today, new data from the phase 3a SCALE™ Obesity and Pre-diabetes trial were presented at the International Congress of Endocrinology (ICE)...

Jun 19, 2014, 09:00 ET
Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir FlexTouch (PRNewsFoto/Novo Nordisk)

Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir® FlexTouch®

Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir®...

Jun 14, 2014, 13:00 ET

New Phase 3 Study Shows Efficacy and Safety of Victoza® (Liraglutide [rDNA origin] Injection) for the Treatment of Type 2 Diabetes in Adults with Moderate Renal Impairment

Data from a new phase 3 study demonstrated that once-daily Victoza® (liraglutide [rDNA origin] injection) provided greater glycaemic control...

Jun 14, 2014, 11:45 ET

New One-year Data of IDegLira Shows Glucose-lowering Effect was Maintained for People with Type 2 Diabetes

New Phase 3a findings show IDegLira, the investigational once-daily single injection combination of insulin degludec and liraglutide, for the...

Jun 14, 2014, 11:30 ET

Phase 3a Data Showed Liraglutide 3 mg Demonstrated Significantly Greater Weight Loss Compared to Placebo in Adults With Obesity and Type 2 Diabetes

Today, primary results from SCALE™ Diabetes, a phase 3a clinical trial of liraglutide 3 mg, an investigational once-daily glucagon-like...

Jun 06, 2014, 09:00 ET

Novo Nordisk Honored with 2014 New Good Neighbor Award by New Jersey Business & Industry Association

Novo Nordisk, a global health care company with more than 90 years of innovation and leadership in diabetes care, will be presented today with a...

May 16, 2014, 06:00 ET

Phase 3a data from largest trial with liraglutide 3 mg demonstrated significantly greater weight loss versus placebo for adults with obesity

 Results from the SCALE™ Obesity and Pre-diabetes phase 3a trial will be presented on May 16, 2014, for the first time at the 23rd Annual...

May 12, 2014, 07:39 ET

NovoEight® reduce las hemorragias en personas con hemofilia A a largo plazo

Hoy Novo Nordisk ha anunciado nuevos datos provisionales de la fase 3 de su ensayo clínico guardian™2 para su producto NovoEight®...

May 12, 2014, 06:38 ET

NovoEight® giver langvarig reduktion i antallet af blødninger hos mennesker med hæmofili A

Novo Nordisk har i dag offentliggjort foreløbige fase 3-data fra guardian™2 studiet for det rekombinante koagulationsfaktor...

May 12, 2014, 06:19 ET

Emofilia: turoctocog alfa riduce nel lungo periodo i sanguinamenti nelle persone con emofilia A

Presentati al congresso della World Federation of Haemophilia (WFH), la più importante manifestazione internazionale dedicata alle malattie...

Apr 08, 2014, 10:30 ET
Novo Nordisk Logo

New Model Needed in Diabetes Care

Urgent need to mobilise and involve people with diabetes in partnership efforts to face the challenges of the diabetes pandemic  Link to...

Mar 28, 2014, 05:43 ET
Novo Nordisk Logo

Novo Nordisk lanza el programa Ciudades Cambiando la Diabetes™ para la lucha contra diabetes urbana

Novo Nordisk anuncia hoy el lanzamiento de Ciudades Cambiando la Diabetes™, un nuevo y ambicioso programa para la lucha contra el reto...

Mar 28, 2014, 05:11 ET
Novo Nordisk Logo

Novo Nordisk lancerer nyt initiativ til at bekæmpe diabetes i verdens storbyer

 Novo Nordisk lancerer i dag 'Cities Changing Diabetes' - et nyt, ambitiøst initiativ, der har til formål at bekæmpe den...

Mar 28, 2014, 05:08 ET
Novo Nordisk Logo

Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes

 Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban...

Mar 28, 2014, 05:07 ET
Novo Nordisk Logo

Novo Nordisk lanza el programa Ciudades Cambiando la Diabetes™ para la lucha contra diabetes urbana

 Novo Nordisk anuncia hoy el lanzamiento de Ciudades Cambiando la Diabetes™, un nuevo y ambicioso programa para la lucha...